Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Optimized human protein inhibits thrombosis and neointima formation in vein grafts

April 24, 2012

Discovery of clinical-stage c-Met inhibitor described

April 24, 2012

New HCV NS5B conformational modulator set for clinical testing

April 24, 2012

First phase II data presented on BMS-791325 in hepatitis C

April 24, 2012

New candidate AstraZeneca antibacterial is active in vivo

April 24, 2012

Canadian study identifies potential new targets for breast cancer therapy

April 23, 2012

Novel PI3Kbeta inhibitor shows potential to treat PTEN-deficient tumors

April 23, 2012

New phase II results on quadruple therapy for treatment-resistant hepatitis C

April 23, 2012

New BTK inhibitor shows promise to treat B-cell malignancies

April 23, 2012

Advaxis describes two new cancer immunotherapies

April 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...